Has Daniel Tomlinson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,562 in general payments to Daniel Tomlinson, MD across 56 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Tomlinson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Tomlinson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Tomlinson, MD

Orthopaedic Surgery · Middletown, NYNPI 1760600431

Payments from drug & device makers

$1,562in general payments, 2019–2025

Across 56 payments — averaging $27.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$882
Zimmer Biomet$231
Stryker$214
Anika Therapeutics, Inc.$104
Seapearl East, Inc$91
Arthrosurface Incorporated$40

What the payments were for

Food & beverage$1,562100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	43	$882
Zimmer Biomet	3	$231
Stryker(2 entities)	5	$214
Anika Therapeutics, Inc.	2	$104
Seapearl East, Inc	2	$91
Arthrosurface Incorporated	1	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,562 in reported general payments places this provider in the 35th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$248,659

Medicare patients

404

Services billed

3,507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	111	$618
Diclofenac Sodium	21	$280
Methylprednisolone	36	$252
Tramadol Hcl	38	$113
Amoxicillin	38	$35
Meloxicam	15	$16

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Middletown

Anthony RomeoNew York$27M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$14.1M
William RicciNew York$11.6M
Steven HaasNew York$11.5M
Giles ScuderiNew York$10.9M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →